Top 10 Pharmaceuticals markets in Japan

The fastest-growing and largest of the 20 sized Pharmaceuticals markets in Japan, 2023 to 2033, with active clinical trials.

Fastest-growing Pharmaceuticals markets in Japan

Top 10 fastest-growing Pharmaceuticals markets in Japan, by CAGR 2023 to 2033
#Market20232033 (projected)CAGRActive trials
1 Biosimilars $2.3 Bn$22.1 Bn 25.4%14
2 Cell Based Immunotherapy $1 Bn$8.5 Bn 23.5%773
3 Cannabidiol (CBD) $1.4 Bn$6.8 Bn 17.3%1
4 Cannabis $2.1 Bn$7.8 Bn 14%0
5 Atopic Dermatitis Drugs $698 Mn$2.3 Bn 12.7%28
6 Oncology/Cancer Drugs $11 Bn$25.8 Bn 8.9%1,084
7 Anti-Aging $5.5 Bn$12.5 Bn 8.6%20
8 Diabetes Management $4.8 Bn$10.1 Bn 7.6%53
9 Alzheimer Drugs $311 Mn$630 Mn 7.3%43
10 Contraceptives Drugs $1.6 Bn$3.2 Bn 7.3%0

Largest Pharmaceuticals markets in Japan

Top 10 largest Pharmaceuticals markets in Japan, by 2023 size
#Market20232033 (projected)CAGRActive trials
1 Oncology/Cancer Drugs $11 Bn$25.8 Bn 8.9%1,084
2 Anti-Aging $5.5 Bn$12.5 Bn 8.6%20
3 Diabetes Management $4.8 Bn$10.1 Bn 7.6%53
4 Gastrointestinal Drugs $3.4 Bn$5.5 Bn 5.1%326
5 Asthma & COPD Drugs $3.1 Bn$4.8 Bn 4.5%55
6 Biosimilars $2.3 Bn$22.1 Bn 25.4%14
7 Cannabis $2.1 Bn$7.8 Bn 14%0
8 HIV Drugs $1.9 Bn$3.4 Bn 6.3%9
9 Contraceptives Drugs $1.6 Bn$3.2 Bn 7.3%0
10 Cancer Supportive Care Drugs $1.5 Bn$2.6 Bn 5.2%132

2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.

Quick answers

What is the fastest-growing Pharmaceuticals market in Japan?

Biosimilars grows fastest, at 25.4% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (23.5%).

What is the largest Pharmaceuticals market in Japan?

Oncology/Cancer Drugs is the largest, worth about $11 Bn in 2023 and $25.8 Bn by 2033 (projected).

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.